Boston Scientific Corp. vs. Pulse Biosciences, Inc Common Stock (DE)
BSX
Boston Scientific Corp.
$43.34 -0.48%
VS PLSEPulse Biosciences, Inc Common Stock (DE)
$53.87 +6.44%
Boston Scientific Corp. (BSX) comes out ahead, leading on 8 of 8 compared factors.
Size & Scale
| BSX | PLSE | |
|---|---|---|
| Market Cap | $63.11 billion | $3.84 billion |
| Revenue (TTM) | $21.00 billion | $1.19 million |
| Net Income (TTM) | $3.67 billion | $-80,056,000 |
BSX leads on 3 of 3 size & scale factors.
Valuation
| BSX | PLSE | |
|---|---|---|
| P/E Ratio | 17.55 | — |
| Price / Book | 2.51 | 38.61 |
| Price / Sales | 3.01 | 3242.32 |
BSX leads on 2 of 2 valuation factors.
Profitability
| BSX | PLSE | |
|---|---|---|
| Net Margin | 17.47% | -6755.78% |
| Return on Equity | 14.58% | -80.46% |
BSX leads on 2 of 2 profitability factors.
Risk & Sentiment
| BSX | PLSE | |
|---|---|---|
| Short Interest | 0.72% | 2.24% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, PLSE overview, PLSE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.